Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

242.76
-1.8500-0.76%
Post-market: 242.760.00000.00%19:39 EDT
Volume:639.94K
Turnover:155.53M
Market Cap:26.79B
PE:25.78
High:245.28
Open:245.17
Low:242.27
Close:244.61
52wk High:247.19
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.72
T/O Rate:0.58%
Dividend:3.32
Dividend Rate:1.37%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.56
PE(LYR):27.74

Loading ...

Quest Diagnostics Receives New York State Approval for Haystack Mrd®, Broadening Patient Access to Ctdna Minimal Residual Disease Testing

THOMSON REUTERS
·
Jun 24

Quest Wins New York State Approval for Haystack MRD Ctdna Test

Reuters
·
Jun 24

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

Quest Diagnostics (DGX) Stock Could Be 12.7% Below Fair Value on Testing Growth Narrative

Simply Wall St.
·
Jun 21

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

Health Rounds: Experimental first-in-class heart drug may also help heal kidneys

Reuters
·
Jun 19

Quest study finds 69.5% of multidrug-resistant Klebsiella pneumoniae non-susceptible to top oral UTI antibiotics

Reuters
·
Jun 18

Quest Diagnostics Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18

Quest Diagnostics to report Q2 results, host earnings call

Reuters
·
Jun 17

Quest Diagnostics releases 2025 Corporate Responsibility Report

Reuters
·
Jun 16

GeneDx names former Quest executive Mark Gardner as president

Reuters
·
Jun 16

Quest Diagnostics highlights 2025 corporate responsibility progress, testing reach and sustainability gains

Reuters
·
Jun 16

Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 09

Quest Diagnostics SVP Clinical Solutions Karthik Kuppusamy disposes of shares worth $1,629,400

Reuters
·
Jun 09

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Quanterix names Geoff Albrecht SVP, diagnostics general manager

Reuters
·
Jun 04

Quest Diagnostics CEO James E. Davis disposes of 10,000 shares worth $1.94 million

Reuters
·
Jun 03

Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy?

Dow Jones
·
May 29